Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients' treatment significantly reduced the risk of major ...
Most people know not to ignore chest pain, the most common symptom of a heart attack. But the warning signs can be much less obvious — especially in women, cardiologists warn. Dismissing them can ...
Add Yahoo as a preferred source to see more of our stories on Google. Illustration of a heart Heart attacks and strokes rarely occur without warning. According to health data from more than 9 million ...
In a new study, heart attack survivors who received a high, personalized dose of daily vitamin D had a 52 percent lower risk of a repeat heart attack. The results suggest specific vitamin D dosing, ...
As a cardiologist, I frequently meet patients who have stopped taking medicines that could keep them alive. Often it's because they've seen a dramatic headline or a worrying TV report about a drug ...
Findings that evolocumab significantly reduced the risk of major adverse CV events in adults at high CV risk without prior heart attack or stroke vs placebo. Topline data were announced from a phase 3 ...
Cardiologists have long warned that heart attacks and strokes rarely arrive without some kind of signal, yet those signals are often subtle enough to dismiss as fatigue, indigestion or a pinched nerve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results